|
|
| 华康生物医学控股有限公司, 08622.HK - 财务比率 |
2022-12 |
2021-12 |
2020-12 |
2019-12 |
2018-12 |
2017-12 |
2016-12 |
2015-12 |
| 变现能力分析 |
| 流动比率(倍) |
5.46 |
6.21 |
6.37 |
8.8 |
5.82 |
3.32 |
2.36 |
1.88 |
| 速动比率(倍) |
5.14 |
5.73 |
6.07 |
8.43 |
5.63 |
3.14 |
2.17 |
1.65 |
| 偿债能力分析 |
| 长期债项/股东权益(%) |
0.1 |
1.15 |
2.0 |
0.61 |
0.0 |
0.0 |
1.45 |
6.02 |
| 总债项/股东权益(%) |
0.83 |
2.92 |
4.27 |
2.28 |
0.0 |
0.0 |
3.93 |
9.83 |
| 总债项/资本运用(%) |
0.83 |
2.88 |
4.16 |
2.25 |
0.0 |
0.0 |
3.83 |
9.1 |
| 投资回报分析 |
| 股东权益回报率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
34.82 |
50.29 |
| 资本运用回报率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
33.95 |
46.6 |
| 总资产回报率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
22.5 |
28.86 |
| 盈利能力分析 |
| 经营利润率(%) |
0.0 |
0.0 |
0.0 |
2.58 |
31.64 |
0.0 |
39.13 |
47.3 |
| 税前利润率(%) |
0.0 |
0.0 |
0.0 |
2.58 |
4.33 |
0.0 |
39.13 |
47.3 |
| 边际利润率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
33.16 |
40.78 |
| 营运能力分析 |
| 存货周转率(倍) |
8.13 |
6.21 |
7.94 |
9.42 |
12.56 |
13.65 |
10.55 |
8.17 |
| 投资收益分析 |
| 派息比率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| 相关统计 |
| 财政年度周最高价 |
0.265 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| 财政年度周最低价 |
0.145 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| 财政年度最高市盈率(倍) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| 财政年度最低市盈率(倍) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| 财政年度最高周息率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| 财政年度最低周息率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
|
|